Recombinant Human CCL2

Recombinant Human CCL2 is an agonist for CCR2, CCR3, CCR5. This product is provided as 5μg of dry powder alongside reconstitution buffer.

Catalog #: 92-1001 Size: 5 µg


Biological Information
Background Information:
CCL2 is a protein involved in chemoattraction which attracts monocytes, activated T cells, basophils, NK cells, and immature dendritic cells to the site of inflammation. CCL2 acts as an agonist on CCR receptors including CCR2, CCR3, and CCR5. Additionally, it is believed to reduce IL-12 production by dendritic cells and promote a Th2 phenotype in CD4+ T cells. Implicated in the pathology of multiple sclerosis, atherosclerosis, and allergic asthma. Provided as 5 μg of dry powder alongside reconstitution buffer.
Target Class:
Target Name:
Product Type:
Recombinant Proteins
Drug Discovery & Development
Storage Conditions:
Store at ≤-20°C. Please avoid multiple freeze/thaw cycles.
Usage Disclaimer:
These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit for a list of products that are governed by limited use label license terms and relevant patent and trademark information.
Additional Information


92-1001 Datasheet

View Document